Sava Infond d.o.o. Buys 80 Shares of Intuitive Surgical, Inc. $ISRG

Sava Infond d.o.o. raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.9% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 8,970 shares of the medical equipment provider’s stock after purchasing an additional 80 shares during the period. Intuitive Surgical accounts for approximately 0.8% of Sava Infond d.o.o.’s investment portfolio, making the stock its 27th biggest position. Sava Infond d.o.o.’s holdings in Intuitive Surgical were worth $4,874,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of ISRG. Aaron Wealth Advisors LLC boosted its stake in Intuitive Surgical by 0.8% during the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock valued at $1,374,000 after purchasing an additional 19 shares during the last quarter. Crown Wealth Group LLC boosted its stake in Intuitive Surgical by 4.8% during the 1st quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider’s stock valued at $218,000 after purchasing an additional 20 shares during the last quarter. FSM Wealth Advisors LLC boosted its stake in Intuitive Surgical by 3.8% during the 1st quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider’s stock valued at $270,000 after purchasing an additional 20 shares during the last quarter. CFO4Life Group LLC boosted its stake in Intuitive Surgical by 4.8% during the 1st quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider’s stock valued at $216,000 after purchasing an additional 20 shares during the last quarter. Finally, J. W. Coons Advisors LLC boosted its stake in Intuitive Surgical by 1.4% during the 1st quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock valued at $741,000 after purchasing an additional 20 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Trading Up 2.1%

NASDAQ:ISRG opened at $452.35 on Friday. The stock has a market capitalization of $162.16 billion, a PE ratio of 63.09, a price-to-earnings-growth ratio of 4.64 and a beta of 1.61. The firm’s 50 day moving average is $463.55 and its 200 day moving average is $500.00. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. Intuitive Surgical’s revenue was up 21.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.78 EPS. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 45,224 shares of company stock valued at $21,716,492. 0.70% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on ISRG shares. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. The Goldman Sachs Group cut their target price on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a research note on Wednesday. BTIG Research restated a “buy” rating and issued a $571.00 target price on shares of Intuitive Surgical in a research note on Wednesday. Piper Sandler restated an “overweight” rating and issued a $595.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Finally, Evercore ISI boosted their target price on Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a research note on Tuesday, July 8th. Fourteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $594.19.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.